TNX-102 FDA Approval Status
FDA Approved: No
Brand name: TNX-102
Generic name: cyclobenzaprine hydrochloride
Company: Tonix Pharmaceuticals Holding Corp.
Treatment for: Fibromyalgia
TNX-102 (cyclobenzaprine) is a sublingual formulation of the approved skeletal muscle relaxant cyclobenzaprine in development for the treatment of pain associated with fibromyalgia.
Development timeline for TNX-102
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.